WEDNESDAY, Oct. 13, 2021 (HealthDay News) — In a development that could mean Johnson & Johnson might encounter resistance over its application for authorization of a booster shot of its coronavirus vaccine, a new analysis filed by the U.S. Food and Drug Administration on Wednesday suggests the company’s evidence mayContinue Reading

WEDNESDAY, Oct. 13, 2021 (HealthDay News) – When Brooklyn-based mom and fashion designer Suzanne Weiner began treatment for breast cancer three years ago, her medical marijuana card was her best friend. “Pot helped me tremendously with the anxiety and stress of my diagnosis,” she said. “I was a mess.” WeinerContinue Reading

TUESDAY, Oct. 12, 2021 (HealthDay News) — Most people shouldn’t bother taking daily low-dose aspirin to reduce their risk of a first heart attack or stroke, the nation’s leading panel of preventive medicine experts announced Tuesday. The U.S. Preventive Services Task Force (USPSTF) issued a draft recommendation that essentially backsContinue Reading

FRIDAY, Oct. 8, 2021 (HealthDay News) — Use of stimulants among college students was once thought to be a problem among high achievers seeking energy and focus to study. Not so, according to new research that links misuse of these so-called “study drugs” to binge drinking and marijuana use. TheContinue Reading

THURSDAY, Oct. 7, 2021 (HealthDay News) — Pfizer Inc. announced Thursday that it has asked the U.S. Food and Drug Administration for emergency approval for its coronavirus vaccine to be given to children between the ages of 5 and 11. “We’re committed to working with the FDA with the ultimateContinue Reading

THURSDAY, Oct. 7 (HealthDay News) — Two new studies confirm that the immunity offered by two doses of Pfizer’s coronavirus vaccine drops off after about two months, although protection against severe disease, hospitalization and death holds strong. The reports, from Israel and Qatar, add to evidence that suggests even fullyContinue Reading